News
Galapagos gets €3.5 mn milestones in osteoarthritis alliance with Servier
Galapagos NV and Servier, a private research based pharmaceutical company, have announced the achievemen milestones under their alliance agreement in osteoarthritis. These milestones trigger payments to Galapagos totalling €3.5 million, which will contribute to the company’s 2011 financial results....
News
Essentialis seeks patent for its investigational compound DCCR
Essentialis Inc., a San Diego-based pharmaceutical company focused on the development of breakthrough medicines targeted to the ATP-sensitive potassium channel, has filed two new patent applications expanding the patent portfolio claiming its investigational triglyceride-lowering compound DCCR and new methods...
News
US FDA extends Eliquis action date by three months
Bristol-Myers Squibb Company, a global biopharmaceutical company, and Pfizer announced that the US Food and Drug Administration (FDA) has extended the action date by three months for the New Drug Application for Eliquis for the prevention of stroke and...
News
Dainippon Sumitomo Pharma signs pact to acquire US biotech company Boston Biomedical
Dainippon Sumitomo Pharma Co., Ltd has reached an agreement to acquire Norwood, Massachusetts-based biotechnology company, Boston Biomedical Inc. Under the terms of the agreement, DSP will make an upfront payment of US$ 200 million to...
News
Inclinix partners with JSW for European enrolment support
Inclinix, a US-based contract research organisation (CRO) that provides customised solutions for patient enrolment to Phase I-IV clinical trials, has raised its profile in Eastern and Western Europe through a formal strategic partnership with JSW Life Sciences, a...
News
KCCI seeks leniency for pharma industry
The Karachi Chamber of Commerce & Industry (KCCI) has expressed discontentment on alleged closure of pharmaceutical industry in the city in the wake of deaths in PIC Lahore due to drug reaction. In a...
News
New suppliers to ease 2 cancer drug shortages
Federal regulators said Tuesday that they've approved new suppliers for two crucial cancer drugs, easing critical shortages - at least for the time being - that have patients worried about missing life-saving treatments. The Food and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read